Solute carrier 11a1 (Slc11a1 ; formerly Nramp1 ; where Nramp stands for natural-resistance-associated macrophage protein) is a proton\bivalent cation antiporter that localizes to late endosomes\lysosomes and controls resistance to pathogens. In the present study the role of Slc11a1 in iron turnover is examined in macrophages transfected with Slc11a1 Gly"'* (wild-type) or Slc11a1 Asp"'* (mutant l functional null) alleles. Following direct acquisition of transferrin (Tf )-bound iron via the Tf receptor, iron uptake and release was equivalent in wild-type and mutant macrophages and was not influenced by interferon-γ\lipopoly-saccharide activation. Following phagocytosis of [&*Fe]Tf-antiTf immune complexes, iron uptake was equivalent and upregulated similarly with activation, but intracellular distribution was markedly different. In wild-type macrophages most iron was in the soluble (60 %) rather than insoluble (12 %) fraction, with 28 % ferritin (Ft)-bound. With activation, the soluble component increased to 82 % at the expense of Ft-bound iron ( 5 %). In
INTRODUCTION
Macrophages play a critical role in iron metabolism. They are responsible for the processing of haemoglobin-iron from senescent erythrocytes and subsequent iron supply to the bone marrow for erythropoiesis [1] . In addition, iron is essential in macrophagemediated cytotoxicity by contributing to the production of highly toxic hydroxyl radicals via the Fenton reaction [2] , and by controlling the production of NO after activation by immunological stimuli [3] . Two new transporters of ferrous iron have been identified. Solute carrier 11a2 (Slc11a2 ; formerly Nramp2 ; where Nramp corresponds to natural-resistance-associated macrophage protein) localizes to early recycling endosomes and is ubiquitous in expression, including macrophages [4] . Slc11a1 (formerly Nramp1) localizes to late endosomes\lysosomes [5, 6] and is more restricted in cellular distribution, principally to cells of the myeloid lineage. Both are polytopic integral membrane proteins with 10-12 predicted membrane-spanning domains. However, whereas Slc11a2 is a symporter of protons and bivalent cations, Slc11a1 is an antiporter that fluxes bivalent cations in either direction depending on the pH on either side of the membrane [7] . Hence, under physiological conditions, Slc11a2 is expected to Abbreviations used : EEA1, early endosome antigen 1 ; FCS, fetal calf serum ; Ft, ferritin ; IFNγ, interferon-γ ; IRP, iron-regulatory protein ; LAMP1, lysosome-associated membrane protein 1 ; LPS, lipopolysaccharide ; L-NMMA, N G -monomethyl-L-arginine ; Nramp, natural-resistance-associated macrophage protein ; NTA, nitrilotriacetate ; Slc11a1/2, solute carrier 11a1/2 ; Tf, transferrin. 1 To whom correspondence should be addressed (e-mail jennie.blackwell!cimr.cam.ac.uk).
mutant macrophages, 40-50 % of iron was in insoluble form, 50-60 % was soluble and 5 % was Ft-bound. Western-blot analysis confirmed failure of mutant macrophages to degrade complexes 24 h after phagocytic uptake. Confocal microscopy showed that complexes were within lysosome-associated membrane protein 1-positive vesicles in wild-type and mutant macrophages at 30 min and 24 h, implying failure in the degradative process in mature phagosomes in mutant macrophages. NOmediated iron release was 2.4-fold higher in activated wild-type macrophages compared with mutant macrophages. Overall, our data suggest that iron acquired by phagocytosis and degradation is retained within the phagosomal compartment in wild-type macrophages, and that NO triggers iron release by direct secretion of phagosomal contents rather than via the cytoplasm.
Key words : macrophage, nitric oxide, phagocytosis. transport bivalent cations from early endosomes to the cytoplasm, whereas Slc11a1 will transport bivalent cations from the cytoplasm into late endosomes, lysosomes and phagosomes. In terms of iron uptake and metabolism within macrophages, this places Slc11a2 in a location likely to influence transferrin (Tf )-receptor-mediated entry of iron into cells, whereas Slc11a1 would be expected to influence degradation and iron recycling from effete erythrocytes entering macrophages by phagocytosis. To test this hypothesis, we compare the fate of intracellular iron acquired either directly through the Tf receptor as Tf-bound iron or following phagocytosis of [&*Fe]Tf-anti-Tf immune complexes in RAW264.7 macrophage cell lines stably transfected with either Slc11a1 Gly"'* (wild-type) or Slc11a1 Asp"'* (mutant l functional null) alleles. nitrilotriacetate (NTA ; Fe\NTA molar ratio of 1 : 4) [8] prepared from Na-NTA and &*FeCl $ (specific radioactivity of 3-10 mCi\ mg ; NEN Life Science Products, Boston, MA, U.S.A.). Human serum albumin (Tf-free), N G -monomethyl--arginine (-NMMA), lipopolysaccharide (LPS), leupeptin, PMSF, benzamidine and pepstatin A were all obtained from Sigma. Nitrocellulose membranes and ECL2 reagents were obtained from Amersham Biosciences (Little Chalfont, Bucks., U.K.). FITC-conjugated annexin V was obtained from Pharmingen (San Diego, CA, U.S.A.), and rabbit anti-(human Tf ) was purchased from Dako (Glostrup, Denmark). Rabbit anti-[mouse ferritin (Ft)] was produced in our laboratory [8] . Mouse recombinant interferon-γ (IFNγ) was kindly provided by Dr G. Adolf (Bender, Vienna, Austria).
Preparation of immune complexes
For radiolabel studies, &*Fe-NTA was added in a quantity sufficient to saturate the iron binding capacity of human apoTf and then optimal proportions of Tf and anti-Tf (normally 1 mg of Tf to 2.5 ml of anti-Tf ) were mixed and incubated at 50 mC for 1 h [9] . The insoluble immune complexes ([&*Fe]Tf-antiTf ) were centrifuged at 500 g for 5 min, washed twice in PBS and resuspended in PBS. For confocal microscopy, cold Fe-NTA was used to prepare immune complexes, which were labelled with FITC by conjugating the Tf using the Sigma Fluorotag kit.
Macrophage cultures and treatments
The RAW264.7 mouse macrophage cell lines stably transfected with wild-type Slc11a1 Gly"'* (7.5R) or mutant Slc11a1 Asp"'* (10S) alleles [10] were maintained in RPMI 1640 medium supplemented with 10 % (v\v) heat-inactivated FCS, 100 units\ml penicillin and 100 µg\ml streptomycin. 
Immunostaining and confocal microscopy
To determine the intracellular fate of immune complexes, macrophages were loaded with 10 µg\ml FITC-labelled Tf-anti-Tf, fixed at intervals and immunostained with antibodies raised against early endosome ogoat polyclonal anti-[early endosome antigen 1 (EEA1)] ; Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.q or late endosomes\lysosome orat monoclonal anti-[lysosome-associated membrane protein 1 (LAMP1)] ID4B ; prepared in-houseq markers. Briefly, 5i10% wild-type or mutant macrophages in 400 µl were plated into the wells of chamber slides (Labtech ; distributed through Gibco) and allowed to settle overnight prior to uptake of immune complexes. Cells were washed in serum-free medium and then incubated in serum-free medium with immune complexes for 1 h at 37 mC. Cells were washed in PBS and either harvested and fixed then, or incubated in RPMI\10 % (v\v) FCS for a further 24 h. Cells were washed in PBS and fixed in ice-cold methanol for 20 min and airdried. Slides were stored at k20 mC. For immunofluorescent staining, cells were rehydrated in PBS and blocked for 1 h at room temperature (21-24 mC) in either PBS containing 5 % (w\v) dried milk powder and 0.1 % Triton X-100 (for LAMP1) or PBS containing 3 % (v\v) horse serum and 0.1 % Triton X-100 (for EEA1). Cells were incubated in a 1 : 100 dilution of primary antibody in an appropriate blocking solution overnight at 4 mC, washed three times for 10 min at room temperature in PBS containing 0.1 % Triton X-100, and incubated for 2 h at room temperature in a 1 : 200 dilution of secondary antibody (goat anti-rat Alex Fluor 594, red, for LAMP1 ; and donkey antigoat Alexa Fluor 594, red, for EEA1 ; Molecular Probes, Europe BV, Leiden, The Netherlands) in appropriate blocking solution. Slides were washed two times for 5 min in PBS containing 0.1 % Triton X-100, washed three times for 5 min in PBS, and mounted in Vectorshield mounting medium (Vector Laboratories, Burlingame, CA, U.S.A.). Preparations were examined using confocal microscopy as previously described [6] .
Iron uptake and release assays
Release of iron into the medium was monitored by determining &*Fe activity in the culture medium at 24 and 48 h intervals using an LKB Compugamma counter. At the end of the experiments, macrophages were lysed in 2 % (w\v) SDS, and the remaining cell-associated radioactivity was determined.
Intracellular distribution of iron
Cells were lysed in 200 µl of cytoplasmic lysis buffer [25 mM Tris\HCl (pH 7.4), 1 % (v\v) Triton X-100, 40 mM KCl, 50 µg\ml leupeptin, 200 µg\ml PMSF, 1 mM benzamidine and 50 µg\ml pepstatin A] and the intracellular iron distribution was determined as described previously [11] . Briefly, this consisted of centrifugation at 10 000 g for 5 min and immunoprecipitation of Ft with a rabbit anti-Ft antibody. This allows separation of intracellular iron into three compartments containing predominantly insoluble material (consisting mainly of undegraded immune complexes and iron bound to intracellular organelles), Ft-bound iron and non-Ft soluble iron.
Estimation of Ft
Macrophages stimulated as described above and pulsed if required with unlabelled immune complexes were lysed with 50-100 µl of boiling lysis solution [1 % (w\v) SDS\10 mM Tris\HCl (pH 7.4)]. Aliquots containing 5-10 µg of protein were analysed by Western blotting using a 15 % (w\v) acrylamide gel and overnight transfer at 150 mA to nitrocellulose membranes. The blots were developed using rabbit anti-(mouse Ft) antibody and ECL2 (Amersham Biosciences) according to the manufacturer's protocol.
Estimation of apoptotic cells
The percentage of cells undergoing apoptosis was determined by flow cytometry using a FITC-annexin-5 kit (Genzyme, Cambridge, MA, U.S.A.) according to the manufacturer's instructions.
Measurement of nitrite
Nitrite in the culture medium was determined using the Griess reagent.
Protein determination
The protein concentration of cell lysates was estimated by the bicinchoninic acid (' BCA ') protein assay reagent (Pierce, Chester, Cheshire, U.K.) using BSA as a standard. Solute carrier 11a1 (Slc11a1) regulation of macrophage iron metabolism
Statistical analysis
Data were analysed by one-way ANOVA and an unpaired Student's t test to determine the difference between each group. Differences were considered statistically significant when P 0.05. (Figure 1a) , the effect being independent of NO. Interestingly, however, IFNγ-and LPS-activated wild-type Slc11a1 macrophages showed a 2.4-fold enhancement (P 0.001) in the amount of iron released compared with mutant Slc11a1 macrophages (Figure 1b) . The trigger for this release was inhibited by -NMMA (P 0.01 for mutant cells ; and P 0.001 for wildtype cells) and was therefore NO-dependent (Figure 1b ). In contrast, no differences in iron uptake (results not shown) or release ( Figure 1c) were observed between wild-type and mutant macrophages when iron was delivered to the macrophages as [&*Fe]Tf. This is consistent with the observation that Slc11a1 is expressed in late endosomes\lysosomes and phagolysosomes, but not in the 
RESULTS
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Figure 3 Co-localization of FITC-labelled FeTf-anti-Tf immune complexes with early endosomal (EEA1) versus late endosome/lysosome (LAMP1) markers in transfected RAW264.7 macrophages
RAW264.7 macrophages transfected with either the non-functional Gly 169
Asp mutant (10S) (a, b and c) or wild-type (7.5R) (d, e and f) Slc11a1were pulsed with immune complexes for 30 min, and were examined by confocal microscopy at 30 
min (a, b and d) or 24 h (c, e and f). (a and d) Green FITC-labelled complexes in cells with nuclei stained with propidium iodide. Immune complexes (green) were located within LAMP1-positive (red) vesicles in mutant (b and c) and wild-type (f) macrophages at 30 min (b) and 24 h (c and f). Vesicles containing immune complexes (green) were almost exclusively negative for EEA1 (red) in both wild-type (e) and mutant (results not shown) macrophages at both 30 min (results not shown) and 24 h (e).
of moribund cells in the wild-type-transfected cells is not the reason for the difference in iron release.
To further investigate the role of Slc11a1 in macrophage iron metabolism, we next investigated the distribution of incorporated iron into the two macrophage cell lines. At 24 h after the [&*Fe]Tf-anti-Tf pulse, mutant-transfected macrophages contained approx. 50 % insoluble iron, whereas wild-type-transfected macrophages contained only approx. 10 % insoluble iron irrespective of the state of activation or NO production ( Figure  1d ). Western-blot analysis revealed that the mutant-, but not the wild-type-, transfected cells still contained a substantial amount of intact rabbit IgG (Figure 2) , indicative of undegraded immune complexes. Using confocal microscopy we were able to detect fluorescent immune complexes in vesicles of both Gly"'* Asp mutant (Figure 3a) and wild-type (Figure 3d ) macrophages. Immunostaining showed that immune complexes co-localized with LAMP1 at 30 min (Figure 3b ) and 24 h (Figures 3c and 3f ) in both Slc11a1 wild-type and mutant cells, with no immune complexes held up in the EEA1-positive (Figure 3e ) early endosomal compartment. Mutant-transfected cells therefore appear to be much less efficient at degrading immune complexes in the late endosomal\lysosomal compartment, consistent with previous studies [12] demonstrating reduced delivery of vacuolarATPase and acidification of phagosomes in mutant compared with wild-type macrophages. In these cells, iron in the insoluble fraction probably corresponded to &*Fe still bound to undegraded insoluble immune complexes, rather than to mitochondria. In contrast, the generally higher soluble non-Ft fraction in the wildtype-transfected macrophages probably consists of iron that has been released from the immune complexes but is still within the phagosome.
The proportion of Ft-bound iron was higher in wild-type macrophages (P 0.0001), with IFNγ and LPS activation causing a marked decrease (P 0.0001) that was partially reversed by -NMMA (P 0.0001). A similar effect was seen in the mutant-transfected macrophages, although the overall proportions of Ft-bound iron were much lower. These results indicate that Slc11a1 promotes iron release from the immune complexes and its subsequent binding by Ft, whereas NO switches the balance towards iron release rather than incorporation into Ft.
Ft expression by Slc11a1-transfected macrophages
To investigate possible mechanisms responsible for the differences in intracellular distribution of iron in mutant-and wild-typetransfected macrophages, we examined Ft expression by the two cell lines. In the first place, it is evident that the mutanttransfected cells contained more Ft than the wild-type-transfected cells, since an exposure of the film that allowed demonstration of regulation of Ft in the mutant-transfected cells gave no bands for the wild-type-transfected cells (Figure 4a ). It can be seen that IFNγ and LPS down-regulated Ft expression in the mutanttransfected cells, the effect being reversed by -NMMA ( Figure  4a ). When the film was overexposed for the mutant-transfected cells in order to allow visualization of Ft in the wild-typetransfected cells, it became evident that although the Ft levels were much lower they were regulated by IFNγ\LPS and - Figure 4 Ft in transfected RAW264.7 macrophages RAW264.7 macrophages transfected with either wild-type Slc11a1 (7.5R) or the non-functional Gly 169 Asp mutant (10S) were treated as in Figure 1 , and Ft expression was determined by Western-blot analysis. NO was measured in the culture supernatant at the time of lysis. In (a) the autoradiograph was exposed for 1 min ; (b) shows the same autoradiograph exposed for 5 min. The 20 kDa bands represent the heavy (21 kDa) and light (20.8 kDa) chains of Ft that co-migrate.
NMMA as in the mutant cells (Figure 4b ). These results indicate that, despite the large overall difference in Ft levels between the two cell lines, in each cell line Ft appears to be down-regulated by NO. This is consistent with results we have obtained comparing bone marrow macrophages from Nos2A wild-type and Nos2A-deficient mice (where Nos2A is the gene for nitric oxide synthase 2A ; V. Mulero, X.-q. Wei, F. Y. Liew and J. H. Brock, unpublished work). However, this effect is overshadowed by the large differences in Ft that are evidently associated with Slc11a1 function.
DISCUSSION
It is well known that mononuclear phagocytes of the liver and spleen acquire iron as a result of erythrophagocytosis during the normal process of removal of effete erythrocytes. However, the mechanisms involved in the liberation of iron by these cells in order for it to be returned to the circulation remain unclear [1] . In the present study we report on studies using uptake of iron via [&*Fe]Tf-anti-Tf immune complexes as a model of iron recycling via erythrophagocytosis. We demonstrate that when iron is delivered to late endosomes\lysosomes via this phagocytic pathway, but not via the Tf receptor in the early recycling endosomes, macrophages stably transfected with the wild-type allele of Slc11a1 recycle 2.4-fold more iron to the medium than mutant macrophages. Release of iron is inhibitable by -NMMA, indicating that NO provides a crucial signal for this iron release. These studies suggest that Slc11a1 plays an important role in recycling of iron acquired by macrophages by phagocytosis, implying a role in degradation and recycling of iron from effete erythrocytes. This is of interest in the light of the role of SLC11A1 in infectious and autoimmune disease susceptibility (reviewed in [13] ), where retention of iron by, or excess deposition of iron around, macrophages is associated with inflammation [14] and can lead to the anaemia of chronic disease [15, 16] .
It has generally been assumed that iron released by macrophages must first enter the cytoplasm from the phagosome for subsequent export across the cytoplasmic membrane, perhaps by a protein analogous to the recently described ferroportin [17] , also known to be expressed in macrophages [18] . In terms of Slc11a1 activity, this pathway would be consistent with the work of Jabado et al. [19] , who used a bivalent-cation-sensitive fluorescent probe covalently attached to zymosan particles to show that phagosomes from Slc11a1 Gly"'* macrophages extrude Mn# + faster than Slc11a1-deficient macrophages. This was demonstrated by measuring the rate of quenching of particlebound fluorescence following addition of a non-physiological level (500 µM) of exogenous Mn# + . The efflux of Mn# + from phagosomes under these conditions could be explained by our earlier observation [7] that Slc11a1 can flux bivalent cations in either direction depending upon the pH, and presumably bivalentcation concentration, on either side of the membrane. An interesting facet of our results in the present study is that, under physiological conditions of low intravacuolar pH, the weight of evidence [7, 20, 21] supports the hypothesis that Slc11a1 transports bivalent cations into, rather than out of, late endosomes\ lysosomes. Hence, a route out of the cell via the cytoplasm for iron acquired by phagocytosis by Slc11a1 wild-type macrophages seems unlikely. This raises the possibility that iron is released from macrophages directly via a lysosomal secretory pathway. Given the potentially damaging influence of high cytoplasmic iron on mRNA stability [22] , this may prove the safest route for recycling of iron from effete erythrocytes. Our results are consistent with earlier studies [23] showing that 40 % of iron acquired from erythrocytes by isolated Kupffer cells, one of the primary sites of Slc11a1 regulated antimicrobial activity [24] , is released within 24 h. However, one issue that remains unclear in this process is the extent to which the release of iron from haem following erthrocyte digestion in macrophages is dependent upon haem oxygenase, and whether this requires cycling via the cytoplasm to access haem oxygenase thought to localize on the cytoplasmic face of the endoplasmic reticulum [25] . Erythrophagocytosis, but not direct iron treatment, has been shown to induce haem oxygenase in human blood monocytes [26] . The localization of haem iron and haem oxygenase in Slc11a1 wildtype and mutant macrophages following erythrophagocytosis would certainly be an area for further fruitful experimentation. Interestingly, we observe that, with macrophage activation, NO triggers the release of iron to the extracellular milieu following phagocytic uptake of iron in our model system. Secretion of lysosomal contents is known to occur in haemopoietic cells [27] , and although there appears to be no data relating specifically to macrophages, NO is known to enhance secretory and\or excretory mechanisms in other cells [28, 29] , which could account for its ability to enhance iron release in the present study. Likewise the failure of mutant Slc11a1-transfected cells to release iron could be explained by defective delivery of the vacuolarATPase and phagosomal acidification [12] , leading to an inability both to degrade immune complexes and to participate in the secretory process. Direct extracellular secretion of iron from phagosomal contents would also imply that most if not all iron entering a cell by phagocytosis never enters the cytoplasm and therefore does not contribute to the cytoplasmic iron pool responsible for regulating iron-regulatory protein (IRP) activity. Loading the cells with iron via Tf-anti-Tf immune complexes had little effect on IRP activity (results not shown) or Ft expression (Figure 4) , compatible with this proposal. Although some radioactive iron was found in Ft, suggesting that some ingested iron can reach the cytoplasm, the amounts are relatively small compared with those seen in J774 cells loaded with Tf [11] and could be explained by the presence of Ft in phagosomes, as it is known that autophagy of Ft can occur [30] . Another factor that may influence iron release is that the mutant cells contained much more Ft than the wild-type cells, even though in both cases Ft levels appeared to be regulated in the same way in response to activation. It has been previously reported that the mutant cells contain more iron than the wild-type cells [31] , and that wildtype cells have increased IRP2 activity [32] . This would explain the high levels of Ft in the mutant cells.
Overall our data provide concrete evidence that Slc11a1 participates in release of iron taken up by macrophages through phagocytosis. While Slc11a1 probably plays a central role in the maintenance of iron homoeostasis in the steady state, its upregulated expression with macrophage activation [6] and known associations with infectious and autoimmune diseases (reviewed in [13] ) make it a primary candidate in regulating the anaemias of chronic disease.
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